Diaphorina citri psyllid: psy12906


Local Sequence Feature Prediction

Prediction and MethodResult
Residue Number Marker
Protein Sequence ?
Secondary Structure (Consensus) ?
Disordered Region (Consensus) ?
Transmembrane Helix (Consensus) ?
Signal Peptide (Consensus) ?
Coiled Coil (COILS) ?
 
--------10--------20--------30--------40--------50--------60--------70--------80--------90-------100-------110-------120-------130-------140-------150-------160-------170-------180-------190-------200-------210-------220-------230-------240-------250-------260-------270-------280-------290-------300---
LVISCDNASYGCTVAVKLDSYSSHLTECEHNPKRPVQCEQGCGSVIPMDELKYLSNQCEYHQHDSHGTDLELSFCTPYQSLHTANTAIMGYEIVRFIGEVDEELICSICSGVFEEPLQDHNCVKELRSIVHKQQQKMVNMETEMSEQRFQMTELKRQLTVLQELMRAMKVSNPGVRVLAENMERDDVARWSNSLSRARVTRWGGMISTPDVMLQAMIKRSLAESGCPGHILDQLMHNSHERNWPQGLSSLETRQNNRRQYENYVCKRIPSKQAVVVLLCDNVHLPEDMISAPGLVMIFAHGIE
cEEEccccccccccEEEcccHHHHHHHccccccccccccccccccccccHHHHHHcccccccccccccHHHHHcccccccHHHHHHHHccHHHHHHHcccHHHHHHHHccccccccccccHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHHcccccccccHHHHHHHHHHHHHHccccccccccccccccccHHHHHHHHHHHHHccccHHHHHHHHHHcccccccccccHHHHHHHHHHHHHHHHHcccccccEEEEEEcccccccccccccccEEEEEEcccc
LVISCDNASYGCTVAVKLDSYSSHLTECEHNPKRPVQCEQGCGSVIPMDELKYLSNQCEYHQHDSHGTDLELSFCTPYQSLHTANTAIMGYEIVRFIGEVDEELICSICSGVFEEPLQDHNCVKELRSIV***************************LTVLQELMRAMKVSNPGVRVLAENM**DDVARWSNSLSRARVTRWGGMISTPDVMLQAMIKRSLAESGCPGHILDQLMHNSHERNWPQGLSSLETRQNNRRQYENYVCKRIPSKQAVVVLLCDNVHLPEDMISAPGLVMIFAHGIE
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
xxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxx
LVISCDNASYGCTVAVKLDSYSSHLTECEHNPKRPVQCEQGCGSVIPMDELKYLSNQCEYHQHDSHGTDLELSFCTPYQSLHTANTAIMGYEIVRFIGEVDEELICSICSGVFEEPLQDHNCxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxxLTVLQELMRAMKVSNPGVRVLAENMERDDVARWSNSLSRARVTRWGGMISTPDVMLQAMIKRSLAESGCPGHILDQLMHNSHERNWPQGLSSLETRQNNRRQYENYVCKRIPSKQAVVVLLCDNVHLPEDMISAPGLVMIFAHGIE

Function Prediction

Annotation transfered from Closely Related SWISS-PROT Entries ?

Annotation ?Function Description ?Confidence Level ?Reference Protein ?
E3 ubiquitin-protein ligase NRDP1 Acts as E3 ubiquitin-protein ligase and regulates the degradation of target proteins. Negatively regulates MYD88-dependent production of proinflammatory cytokines but can promote TRIF-dependent production of type I interferon. Promotes also activation of TBK1 and IRF3. Involved in the ubiquitination of erythropoietin (EPO) and interleukin-3 (IL-3) receptors. Thus, through maintaining basal levels of cytokine receptors, FLRF is involved in the control of hematopoietic progenitor cell differentiation into myeloerythroid lineages. Contributes to the maintenance of steady-state ERBB3 levels by mediating its growth factor-independent degradation. Involved in the degradation of the inhibitor of apoptosis BIRC6 and thus is an important regulator of cell death by promoting apoptosis. Acts also as a PARK2 modifier that accelerates its degradation, resulting in a reduction of PARK2 activity, influencing the balance of intracellular redox state.confidentQ5R7T5
E3 ubiquitin-protein ligase NRDP1 Acts as E3 ubiquitin-protein ligase and regulates the degradation of target proteins.confidentQ7ZW16
E3 ubiquitin-protein ligase NRDP1 Acts as E3 ubiquitin-protein ligase and regulates the degradation of target proteins. Contributes to the maintenance of steady-state ERBB3 levels by mediating its growth factor-independent degradation. Involved in the degradation of the inhibitor of apoptosis BIRC6 and thus is an important regulator of cell death by promoting apoptosis. Acts also as a PARK2 modifier that accelerates its degradation, resulting in a reduction of PARK2 activity, influencing the balance of intracellular redox state. Polyubiquitinates MYD88 (By similarity). Negatively regulates MYD88-dependent production of proinflammatory cytokines but can promote TRIF-dependent production of type I interferon and inhibits infection with vesicular stomatitis virus. Promotes also activation of TBK1 and IRF3. Involved in the ubiquitination of erythropoietin (EPO) and interleukin-3 (IL-3) receptors. Thus, through maintaining basal levels of cytokine receptors, FLRF is involved in the control of hematopoietic progenitor cell differentiation into myeloerythroid lineages.confidentQ8BH75

Prediction of Gene Ontology Terms ?

GO Term ?Description ?Confidence Level ?Parent GO Terms ?
GO:0051896 [BP]regulation of protein kinase B signaling cascadeprobableGO:0009966, GO:0048583, GO:0050794, GO:0065007, GO:0023051, GO:0008150, GO:0010646, GO:0010627, GO:0050789
GO:0005128 [MF]erythropoietin receptor bindingprobableGO:0005126, GO:0005102, GO:0003674, GO:0005488, GO:0005515
GO:0005135 [MF]interleukin-3 receptor bindingprobableGO:0005126, GO:0070851, GO:0003674, GO:0005488, GO:0005515, GO:0005102
GO:2000377 [BP]regulation of reactive oxygen species metabolic processprobableGO:0019222, GO:0031323, GO:0050794, GO:0008150, GO:0065007, GO:0050789
GO:0004842 [MF]ubiquitin-protein ligase activityprobableGO:0019787, GO:0016879, GO:0016881, GO:0003824, GO:0003674, GO:0016874
GO:0051445 [BP]regulation of meiotic cell cycleprobableGO:0051726, GO:2000241, GO:0050794, GO:0008150, GO:0065007, GO:0050789
GO:0045637 [BP]regulation of myeloid cell differentiationprobableGO:0050793, GO:0050794, GO:0008150, GO:0045595, GO:0065007, GO:2000026, GO:0051239, GO:0002682, GO:0050789
GO:0000209 [BP]protein polyubiquitinationprobableGO:0071704, GO:0044267, GO:0044238, GO:0044260, GO:0032446, GO:0019538, GO:0009987, GO:0070647, GO:0006464, GO:0043170, GO:0016567, GO:0043412, GO:0036211, GO:0008150, GO:0044237, GO:0008152
GO:0043408 [BP]regulation of MAPK cascadeprobableGO:0009966, GO:0048583, GO:0050794, GO:0065007, GO:0023051, GO:0008150, GO:0010646, GO:0010627, GO:0050789
GO:0008285 [BP]negative regulation of cell proliferationprobableGO:0042127, GO:0050794, GO:0008150, GO:0065007, GO:0048519, GO:0050789, GO:0048523
GO:0045619 [BP]regulation of lymphocyte differentiationprobableGO:0051249, GO:0050865, GO:0050793, GO:1902105, GO:0050794, GO:0008150, GO:0002694, GO:0045595, GO:0065007, GO:0002682, GO:0051239, GO:2000026, GO:0050789
GO:0030336 [BP]negative regulation of cell migrationprobableGO:0040013, GO:0051270, GO:0065007, GO:0051271, GO:0040012, GO:0008150, GO:0030334, GO:2000145, GO:2000146, GO:0048519, GO:0032879, GO:0050794, GO:0050789, GO:0048523
GO:0006917 [BP]induction of apoptosisprobableGO:0050789, GO:0043067, GO:0050794, GO:0043065, GO:0048518, GO:0012502, GO:0065007, GO:0010942, GO:0008150, GO:0010941, GO:0042981, GO:0043068, GO:0048522

Prediction of Enzyme Commission Number ?

No confident prediction of EC number!


Spatial Structural Prediction

Structural Models Based on Templates

Template: 2FZP, chain A
Confidence level:very confident
Coverage over the Query: 175-303
View the alignment between query and template
View the model in PyMOL
Template: 2YUC, chain A
Confidence level:confident
Coverage over the Query: 19-86
View the alignment between query and template
View the model in PyMOL
Template: 1FLK, chain A
Confidence level:probable
Coverage over the Query: 127-229
View the alignment between query and template
View the model in PyMOL
Template: 2YRE, chain A
Confidence level:probable
Coverage over the Query: 34-61,80-108
View the alignment between query and template
View the model in PyMOL